2017 Regulatory Data Shows a Friendlier FDA

article image

An innovation friendly FDA led to more device approvals and faster review times this year.

S ome 91% of PMAs (premarket applications) and panel-track supplements were approved by FDA in fiscal 2017 (ended September), the second highest approval rate since 2001; the pinnacle to date was 95% in 2015.


This article is restricted to subscribers only.

Sign in to continue reading.


We're here to help! Please contact us at: